Page last updated: 2024-08-24

oseltamivir and histamine

oseltamivir has been researched along with histamine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrianova, EN; Aver'ianov, AV; Babkin, AP; Bart, BIa; Epshteĭn, OI; Kostinov, MP; Kozyrev, OA; Minina, ES; Nechaev, VB; Petrov, DV; Putilovskiĭ, MA; Sel'kova, EP; Volchetskiĭ, AL1
Andrianova, E; Averyanov, A; Bart, B; Epstein, O; Minina, E; Putilovskiy, M; Rafalsky, V1
Borshcheva, AA; Emelyanova, AG; Epstein, OI; Gorbunov, EA; Mazurkov, OY; Petrova, NV; Shishkina, LN; Skarnovich, MA; Skarnovich, MO; Tarasov, SA1

Trials

2 trial(s) available for oseltamivir and histamine

ArticleYear
[Ergoferon and oseltamivir in treatment of influenza: results of multicentre randomized comparative clinical trial].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2012, Volume: 57, Issue:7-8

    Topics: Adolescent; Adult; Antipyretics; Antiviral Agents; Body Temperature; CD4 Antigens; Female; Fever; Histamine; Humans; Influenza, Human; Interferon-gamma; Male; Middle Aged; Oseltamivir; Russia; Time Factors; Treatment Outcome; Young Adult

2012
Efficacy and safety of Ergoferon versus oseltamivir in adult outpatients with seasonal influenza virus infection: a multicenter, open-label, randomized trial.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2016, Volume: 51

    Topics: Adolescent; Adult; Aged; Antibodies; Antiviral Agents; CD4 Antigens; Female; Fever; Histamine; Humans; Influenza, Human; Interferon-gamma; Male; Middle Aged; Oseltamivir; Outpatients; Quality of Life; Time Factors; Treatment Outcome; Young Adult

2016

Other Studies

1 other study(ies) available for oseltamivir and histamine

ArticleYear
Activity of ergoferon against lethal influenza A (H3N2) virus infection in mice.
    Antiviral therapy, 2017, Volume: 22, Issue:4

    Topics: Animals; Antibodies; Antiviral Agents; CD4 Antigens; Drug Administration Schedule; Drug Dosage Calculations; Female; Histamine; Immunologic Factors; Influenza A Virus, H3N2 Subtype; Interferon-gamma; Longevity; Lung; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir; Survival Analysis; Treatment Outcome; Viral Load

2017